Overview

• Northern TK Venture (NTK), a subsidiary of IHH Healthcare, has amended its Tokyo District Court petition to seek JPY 200 billion (₹11,800 crore) in damages from Daiichi Sankyo.
• The revised claim includes compensation for defamation losses and accrued interest, reflecting allegations of obstruction during NTK’s 2018 open offer for Fortis Healthcare shares.
• An independent expert report by Osborne Partners, commissioned in February 2025, estimated NTK’s potential losses between ₹4.24 billion and ₹109.3 billion under three counterfactual scenarios.
• The original claim, filed in October 2023, sought JPY 20 billion, but NTK now reserves the right to further amend the damages as it alleges ongoing harm.
• The next preparatory hearing in the case is scheduled for July 11, 2025, with Daiichi Sankyo yet to issue a public response to the amended claim.